On June 30, PegBio-B (02565.HK) declined 8.3% in regular trading, trading at HK$5.31/share, with turnover of approximately HK$26.38 million.

The decline is attributed to ongoing selling pressure following the completion of the company's H-share full circulation scheme. On June 25, approximately 101.7 million previously unlisted shares were converted into H-shares and began trading on June 26, raising the H-share proportion from 72.69% to 98.70% of total issued shares. The influx of newly tradeable shares significantly increased the supply of available stock in the market.

The stock hit an all-time low of HK$4.96 on June 26 amid concentrated selling. While it rebounded over 17% on June 29 as initial selling pressure eased, today's renewed decline indicates that the overhang from the newly circulated shares has not been fully absorbed, with the stock remaining in a phase of heightened volatility as the market digests the expanded free float.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)